Health Law Pulse
Rick Robinson

Pharma in Focus recently interviewed Rick Robinson, Norton Rose Fulbright’s global co-head of life science and healthcare and his Australian colleague  and Norton Rose Fulbright partner Richard Fogl.

Norton Rose Fulbright - Health Law Pulse
Richard Fogl

Discussing Australia’s drive for more transparency in the medical systems, both Robinson and Fogl caution within the article that “Australia should not ‘rush’ into a system of greater reporting until the US experience becomes clearer.”

Read the full article, Legal warning on new transparency.

Pharma in Focus is a periodical that covers the pharma sector—both prescription and non-prescription—in Australia and New Zealand.

Leave a Reply

Your email address will not be published. Required fields are marked *